← Evidence map

ReviewCurrent hematologic malignancy reports2017

The Future of Targeting FLT3 Activation in AML.

Mark B Leick et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled itcites it